A Combined Chemical, Computational, and In Vitro Approach Identifies SBL-105 as Novel DHODH Inhibitor in Acute Myeloid Leukemia Cells.

Kamli, Hossam; Zaman, Gaffar S; Shaikh, Ahmad; Mobarki, Abdullah A; Rajagopalan, Prasanna

Kamli, Hossam; Zaman, Gaffar S; Shaikh, Ahmad; Mobarki, Abdullah A; Rajagopalan, Prasanna.

Afiliación

Kamli H; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid UniversityAbhaSaudi Arabia.
Zaman GS; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid UniversityAbhaSaudi Arabia.
Shaikh A; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid UniversityAbhaSaudi Arabia.
Mobarki AA; Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, Jazan UniversityJazanSaudi Arabia.
Rajagopalan P; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid UniversityAbhaSaudi Arabia.

Oncol Res ; 28(9): 899-911, 2022 Jan 31.

Article en En | MEDLINE | ID: mdl-34353411

Asunto(s)

Leucemia Mieloide Aguda; Oxidorreductasas actuantes sobre Donantes de Grupo CH-CH; Ciclo Celular; Dihidroorotato Deshidrogenasa; Inhibidores Enzimáticos; Humanos; Leucemia Mieloide Aguda/tratamiento farmacológico

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Oxidorreductasas actuantes sobre Donantes de Grupo CH-CH Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Oncol Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google